Immuneel Therapeutics Private Limited, a active private limited company, was established on 20 December 2018 in Bengaluru, Karnataka, India. Engaging in oncology clinics & cancer treatment within the professional, scientific and technical sector, it holds CIN: U24230KA2018PTC119691. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹0.46 M.
Employing 96 professional, Its leadership includes Kiran Mazumdar Shaw (Director), Siddhartha Mukherjee (Director), Prem Venkatachalam Pavoor (Director). Past directors included Arun Anand, Amit Mookim. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 29/P2, 8Th Floor, Narayana Health City Hosur Road, Bommasandra Industrial Area,, Bengaluru, Karnataka, 560099.
U24230KA2018PTC119691
119691
20 December 2018
₹100.00 Cr
₹0.46 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Immuneel Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Mazumdar Shaw | Director | 20 Dec 2018 | Current |
| Siddhartha Mukherjee | Director | 20 Apr 2022 | Current |
| Prem Venkatachalam Pavoor | Director | 20 Apr 2022 | Current |
| Ranjan Ramdas Pai | Director | 20 Dec 2018 | Current |
| Amit Mookim | Director | 06 Sep 2024 | Current |
| Saif Khalfan Mohamed Al Hasani | Director | 29 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Jul 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Immuneel Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 441.27% increase. The company also saw a substantial fall in profitability, with a 26.81% decrease in profit. The company's net worth Soared by an impressive increase of 177.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Immuneel Therapeutics had a public holding of 68.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Immuneel Therapeutics has a workforce of 96 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Immuneel Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Immuneel Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Immuneel Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Amit Mookim was appointed as a Director was appointed as a Director on 06 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
Saif Khalfan Mohamed Al Hasani was appointed as a Director was appointed as a Director on 29 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
Progress on Immuneel Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The activity Siddhartha Mukherjee was appointed as a Director was appointed as a Director on 20 Apr 2022 & has been associated with this company since 3 years 7 months . was completed.
Progress on Prem Venkatachalam Pavoor was appointed as a Director was appointed as a Director on 20 Apr 2022 & has been associated with this company since 3 years 7 months . was documented.
TECH NEWS : L&T's LTSCT will acquire SiliConch Systems for Rs 183 crore, with Rs 133 crore upfront and Rs 50 crore deferred over four years. SiliConch has 30 pate.
Immuneel is the first startup from India to receive this award At the Endpoints News Awards in Boston, USA, Immuneel Therapeutics, India’s leading clinical-stage cell and gene therapy startup, was nam.
The settlement between Statera Biopharma, Inc. and Biostax Corp. .......
The CIN of Immuneel Therapeutics Private Limited is U24230KA2018PTC119691.
Immuneel Therapeutics Private Limited is headquartered at 29/P2, 8Th Floor, Narayana Health City Hosur Road, Bommasandra Industrial Area,, Bengaluru, Karnataka, 560099.
Immuneel Therapeutics Private Limited was incorporated on 20 December 2018.
The current directors of Immuneel Therapeutics Private Limited are
The primary industry of Immuneel Therapeutics Private Limited is Professional, Scientific And Technical.
Immuneel Therapeutics Private Limited is unlisted.
The authorized capital of Immuneel Therapeutics Private Limited is ₹100.00 Cr, and the paid-up capital is ₹0.46 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX